Matinas BioPharma Holdings Inc (MTNB)

Matinas BioPharma Holdings Inc (MTNB) is a Biotechnology company in the Healthcare sector listed on the AMEX.

As of Oct 23, 2026: market cap $1.7M; returns 1 day -0.5%, 1 week -28.2%, 1 year -92.8%.

Matinas BioPharma Holdings, Inc. is a clinical-stage biopharmaceutical company focused on developing pharmaceutical products using its lipid nanocrystal (LNC) platform technology. Their LNC platform enables the oral delivery of small molecules and small oligonucleotides. The company's lead product candidate is MAT2203 (oral amphotericin B), which is being advanced under FDA guidance.

Groups MTNB belongs to

• Recent Reverse Splits
• Clinical Stage Biotech
• Biotechnology
• Healthcare
• Life Sciences
• Biopharmaceutical
• Infectious Diseases
• Clinical Stage
• R&D
• Drug Discovery

MTNB financial model: income statement, cash flow and balance sheet